ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 125 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $417,219 | +172.1% | 139,073 | +239.3% | 0.00% | +200.0% |
| Q2 2023 | $153,310 | -39.4% | 40,992 | -45.8% | 0.00% | -50.0% |
| Q1 2023 | $253,133 | +28.0% | 75,562 | +83.7% | 0.00% | +100.0% |
| Q4 2022 | $197,806 | +4.7% | 41,124 | +54.3% | 0.00% | 0.0% |
| Q2 2022 | $189,000 | -79.0% | 26,656 | -78.6% | 0.00% | -87.5% |
| Q1 2022 | $899,000 | -76.4% | 124,540 | -70.8% | 0.01% | -77.8% |
| Q4 2021 | $3,807,000 | +1254.8% | 425,820 | +5206.2% | 0.04% | +800.0% |
| Q3 2021 | $281,000 | -71.2% | 8,025 | -82.3% | 0.00% | -63.6% |
| Q2 2021 | $976,000 | +222.1% | 45,457 | +827.7% | 0.01% | +175.0% |
| Q1 2021 | $303,000 | – | 4,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |